Records containing: Pulmonary Tuberculoses
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Immunological and Epidemiological Features of the Influence of Concomitant Infections on the Course and Outcome of Chronic Respiratory Diseases
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of Nebulised RESP30TB in Adults With Newly Diagnosed, Rifampicin Susceptible Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2025-09-12Evaluating the PATHFAST TB LAM Ag Assay as a Treatment Monitoring Tool for Pulmonary Tuberculosis: A Prospective Longitudinal Study in Nairobi, Kenya
-
CLINICAL_TRIALS study record update · 2025-04-04Prevalence of Chronic Pulmonary Aspergillosis and Antifungal Drug Resistance of Aspergillus Spp. in Pulmonary Tuberculosis Patients in Uzbekistan
-
CLINICAL_TRIALS study record update · 2025-02-10Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-10Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-04-22Economic Evaluation of New MDR TB Regimens (PRACTECAL EE)
-
CLINICAL_TRIALS study record update · 2023-11-22Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-02-17Prevalence and Burden of Bronchiectasis in Tuberculous Patients
-
CLINICAL_TRIALS study record update · 2022-10-05Time-to-Detection in Culture of Mycobacterium Tuberculosis : Performance for Assessing Index Cases Infectivity
-
CLINICAL_TRIALS study record update · 2022-08-10A Prospective Phase Ib/IIa, Active-controlled, Randomized, Open-label Study to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Multiple Oral Doses of BTZ-043 Tablets in Subjects With Newly Diagnosed, Uncomplicated, Smear-positive, Drug-susceptible Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2022-07-28A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
-
CLINICAL_TRIALS study record update · 2021-10-28Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.
-
CLINICAL_TRIALS study record update · 2021-10-15Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
-
CLINICAL_TRIALS study record update · 2019-01-11A Open-label, Dose Escalation, Phase 1 Clinical Trial to Evaluate the Tolerability, Safety and Immunogenicity of GX-70, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation (EP) in Patients With Pulmonary Tuberculosis Who Have High Risk Factors for Relapse or Treatment Failure
-
CLINICAL_TRIALS study record update · 2017-02-14Multi-center Study to Assess the Non-inferiority of YD REBA MTB-MDR® and Hain GenoType® MTBDRplus V2 Line Probe Assays Compared to Hain GenoType® MTBDRplus V1